ARF3
ADP-ribosylation factor 3
Also known as: ARF3_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P61204
- Gene
- ARF3
- Ensembl
- ENSG00000134287
- Chromosome
- 12
- Canonical length
- 181 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins
OverviewNCBI Gene
ADP-ribosylation factor 3 (ARF3) is a member of the human ARF gene family. These genes encode small guanine nucleotide-binding proteins that stimulate the ADP-ribosyltransferase activity of cholera toxin and play a role in vesicular trafficking and as activators of phospholipase D. The gene products include 6 ARF proteins and 11 ARF-like proteins and constitute one family of the RAS superfamily. The ARF proteins are categorized as class I (ARF1, ARF2,and ARF3), class II (ARF4 and ARF5) and class III (ARF6) and members of each class share a common gene organization. [provided by RefSeq, Oct 2022]
Canonical amino-acid sequenceUniProt
181 residues, UniProt reviewed canonical sequence.
>P61204|ARF3
1 MGNIFGNLLK SLIGKKEMRI LMVGLDAAGK TTILYKLKLG EIVTTIPTIG FNVETVEYKN
61 ISFTVWDVGG QDKIRPLWRH YFQNTQGLIF VVDSNDRERV NEAREELMRM LAEDELRDAV
121 LLVFANKQDL PNAMNAAEIT DKLGLHSLRH RNWYIQATCA TSGDGLYEGL DWLANQLKNK
181 KLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ARF3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 271 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 271 nTPM
- basal ganglia: 248 nTPM
- amygdala: 184 nTPM
- hippocampal formation: 174 nTPM
- hypothalamus: 138 nTPM
- parathyroid gland: 130 nTPM
Single-cell type
- platelets: 37 nCPM
- late spermatids: 31 nCPM
- megakaryocytes: 19 nCPM
- brain inhibitory neurons: 15 nCPM
- brain excitatory neurons: 14 nCPM
- other brain neurons: 13 nCPM
Immune cell
- neutrophil: 55 nTPM
- myeloid DC: 52 nTPM
- plasmacytoid DC: 40 nTPM
- classical monocyte: 39 nTPM
- eosinophil: 28 nTPM
- intermediate monocyte: 25 nTPM
Brain region
- cerebral cortex: 395 nTPM
- basal ganglia: 362 nTPM
- hippocampal formation: 360 nTPM
- hypothalamus: 317 nTPM
- amygdala: 252 nTPM
- white matter: 250 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ARF3.
Disease | GeneticClinVar
10 pathogenic / likely-pathogenic of 41 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Intellectual disability
- Atrophy/Degeneration affecting the central nervous system
- ARF3-related disorder
- Microcephaly
- Scoliosis
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.72
- gnomAD pLI
- 0.35
- gnomAD missense Z
- 2.82
- DepMap mean gene effect
- -0.23
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- intracellular protein transport
- retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum
- vesicle-mediated transport
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ARF3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ARF3 as an antibody target. Whether an autoantibody or antibody against ARF3 could matter depends on whether native ARF3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ARF3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ARF3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...